Iress appoints new non-executive director to board
Joining this October. Iress has announced the appointment of Anthony Glenning to its board as an independent non-executive director. Mr Glenning – who is currently the fund manager for seed invest
Stay updated with breaking news from Pro Medicus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Joining this October. Iress has announced the appointment of Anthony Glenning to its board as an independent non-executive director. Mr Glenning – who is currently the fund manager for seed invest
Many Australian companies are feeling the pinch from soaring energy costs.
REA Group Limited (ASX:REA) and this ASX 200 share could be in the buy zone after the selloff. Here's what you need to know about them...
When you think about return on investment, it doesn’t get much better than Pro Medicus’ 2009 acquisition of imaging technology company Visage.
Pro Medicus shares are up 42 per cent since mid-June, on the back of a series of new contract wins which will flow through to its earnings in 2023.